Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Caffeine for ELBW Newborns
NCT02524249Terminated
- Sponsor
- Wayne State University
- Start
- Sep 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of caffeine in bronchopulmonary dysplasia (BPD) and apnea of prematurity (AOP) (2 arms), sponsored by Wayne State University. Primary endpoint: Cumulative incidence of death and bronchopulmonary dysplasia. Started Sep 2015; status: terminated.
02
Drugs
caffeine
03
Conditions
bronchopulmonary dysplasia (BPD)apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT02524249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524249.